Tap these resources on Medicare's oral anti-emetic policy.
If your practice reports oral anti-emetics, be sure you're up on the latest ondansetron coding news or you could start seeing denials.
This drug received a new HCPCS code, effective Jan. 1, 2012: Q0162 (Ondansetron 1 mg, oral, FDA approved prescription anti-emetic, for use as a complete therapeutic substitute for an IV anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen).
To make room for this new code, HCPCS deleted Q0179 (Ondansetron hydrochloride 8 mg, oral, FDA approved prescription anti-emetic, for use as a complete therapeutic substitute for an [...]
- Published on 2012-01-17